stella
beta
CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention — Stella
Recruiting
Back to ACS - Acute Coronary Syndrome trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
China
Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou
View full record on ClinicalTrials.gov